Conference Videos

CardioFocus Announces European CE Mark Approval Of HeartLight X3 System
News | Ablation Systems | April 16, 2019

April 16, 2019 — CardioFocus Inc. announced the European CE Mark approval of the HeartLight X3 Endoscopic...

A comparison of the first-ever image of a black hole released this week by the Event Horizon Telescope collaboration et al. and a cardiac nuclear imnaging exam. Left if the black hole, right, is a similar nuclear imaging exam of the heart showing a similar ischemic perfusion defect to the black hole.  Comparison of black hole photo to a cardiac exam.

A comparison of the first-ever image of a black hole released this week by the Event Horizon Telescope collaboration et al. and a cardiac nuclear imaging exam. Left is the black hole, and right is a similar nuclear imaging exam of the heart showing a similar ischemic perfusion defect to the black hole.  

Blog | Nuclear Imaging | April 12, 2019

This week, cardiologists learned for the first time they have been examining black holes for decades and did not...

DiA Imaging Analysis Introduces LVivo SAX Ultrasound Analysis Tool
Technology | Cardiovascular Ultrasound | April 09, 2019

April 9, 2019 — DiA Imaging Analysis announced the launch of LVivo SAX, a cardiac analysis tool that helps...

 The ScImage cloud-based PICOM365 enterprise cardiology is one of the newer generation echo reporting solutions that offers several ways to streamline workflow.

 The ScImage cloud-based PICOM365 enterprise cardiology is one of the newer generation echo reporting solutions that offers several ways to streamline workflow.

Feature | Cardiovascular Ultrasound | April 08, 2019 | Dave Fornell, Editor

Echocardiography reporting systems are usually integrated with, or offered as an add-on module for a...

HeartHero Personal Automated External Defibrillator Wins ACC.19 Innovation Challenge
News | Defibrillator Monitors | April 05, 2019

April 5, 2019 — Medical device startup HeartHero was the winner in the Innovation Challenge at the...

 Evolut Low Risk Trial compared the minimally invasive Evolut transcatheter aortic valve replacement (TAVR) system to the gold standard of open-heart surgery in characteristically younger, healthier aortic stenosis patients. The randomized trial, which met its primary non-inferiority endpoint of all-cause mortality or disabling stroke at two years compared to surgery (5.3 vs. 6.7 percent; posterior probability of non-inferiority >0.999), was presented at the American College of Cardiology (ACC) 2019 meeting
News | Heart Valve Technology | April 03, 2019

April 3, 2019 – The ACC.19 late-breaking landmark Evolut Low Risk Trial compared the minimally invasive Evolut...

The top cardiac technology news item in March was the FDA clearing the MitraClip for use in heart failure patients with functional mitral regurgitation based on the very positive results of the COAPT Trial.

The top cardiac technology news item in March was the FDA clearing the MitraClip for use in heart failure patients with functional mitral regurgitation based on the very positive results of the COAPT Trial.

Feature | April 01, 2019

April 1, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)...

Diabetes Drug Effective Against Heart Failure in Wide Spectrum of Patients
News | Heart Failure | March 29, 2019

March 29, 2019 — The cardiovascular benefits of the diabetes...

Vascepa Markedly Reduces First, Repeat and Total Cardiovascular Events
News | Pharmaceuticals | March 29, 2019

March 29, 2019 — Taking a high dose of icosapent ethyl significantly reduces the occurrence of first, subsequent and...

New Stroke Training Model Improves Access to Life-Saving Care
News | Stroke | March 27, 2019

March 27, 2019 — Training ...

New data from a four-week extension of the landmark PIONEER-HF Trial showed the drug sacubitril/valsartan (Entresto) continued to deliver reductions in the heart failure biomarker N-terminal pro–B-type natriuretic peptide (NT-proBNP), an established biomarker for heart failure severity and prognosis.[1] The data was presented as a late-breaker at the American College of Cardiology (ACC) 2019 Annual Scientific Session in March.
News | Heart Failure | March 27, 2019

March 27, 2019 —New data from a four-week extension of the landmark PIONEER-HF Trial showed the drug sacubitril/...

SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions. FFR in the cath lab.

SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions.

Feature | ACC | March 27, 2019 | Greg Freiherr, Contributing Editor
The fingerprints of value-added medicine were all over products and works-in-progress on the exhibit floor of the...
Overlay Init